Personalized Phenobarbital Treatment and Monitoring System
Legal Citation
Summary of the Inventive Concept
A next-generation phenobarbital treatment system that leverages machine learning, nanotechnology, IoT, and blockchain to provide personalized treatment plans, real-time monitoring, and secure supply chain management.
Background and Problem Solved
The original patent disclosed a lyophilized pharmaceutical composition of phenobarbital sodium for injection, but it has limitations in terms of dosing, side effects, and supply chain integrity. The new inventive concept addresses these limitations by introducing advanced technologies to create a more efficient, effective, and secure treatment system.
Detailed Description of the Inventive Concept
The system comprises a machine learning algorithm that predicts optimal dosage and administration schedules based on a patient's genetic profile and medical history. It also includes a wearable sensor and a cloud-based analytics platform for real-time monitoring of phenobarbital levels in a patient's bloodstream. Additionally, a novel formulation of phenobarbital sodium utilizing nanotechnology enhances bioavailability and reduces side effects. The system is secured by a decentralized, blockchain-based platform for tracking and verifying the authenticity of phenobarbital products throughout the supply chain. Furthermore, a closed-loop system for optimizing phenobarbital dosing in real-time uses a brain-computer interface to detect seizure activity and adjusts medication levels accordingly, with a feedback mechanism that refines the system's performance over time.
Novelty and Inventive Step
The new claims introduce a paradigm shift in phenobarbital treatment by integrating cutting-edge technologies to provide personalized, real-time, and secure treatment. The inventive step lies in the combination of machine learning, nanotechnology, IoT, and blockchain to create a holistic treatment system that addresses the limitations of the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include variations in the machine learning algorithm, nanotechnology formulation, or blockchain platform. For example, the system could be adapted for use with other pharmaceutical compounds or expanded to include additional features such as patient engagement tools or healthcare provider dashboards.
Potential Commercial Applications and Market
The personalized phenobarbital treatment and monitoring system has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the areas of precision medicine, digital health, and supply chain management. The market for this system is expected to grow as the demand for personalized and effective treatment options increases.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K9/19 |
| A | A61 | A61K9/08 |
| A | A61 | A61K31/515 |
| A | A61 | A61K47/10 |
| A | A61 | A61P25/08 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical formulation and drug delivery systems, specifically focused on neurological medications, with expertise in nanotechnology, machine learning, and personalized medicine approaches
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmaceutical sciences, biotechnology, or biomedical engineering, possessing knowledge of drug formulation, medical device design, and emerging digital health technologies
Obviousness Rationale
A PHOSITA would recognize that the published technical disclosure represents a predictable combination of known technologies applied to the existing phenobarbital sodium formulation, leveraging standard techniques in personalized medicine, nanotechnology, and digital health monitoring to extend the original patent's pharmaceutical innovation.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,683 |
|---|---|
| Title | Stabilization of phenobarbital sodium for injection |
| Assignee(s) | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED |